Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Scandinavian Journal of Urology|May 6, 2014
Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancerJoen Sveistrup, Anders Widmark, Per Fransson, et al.
Radiation Oncology (London, England)|January 2, 2023
Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II studyUlrika Björeland, Kristina Notstam, Per Fransson, et al.
BJU International|May 12, 2015
Population-based study of long-term functional outcomes after prostate cancer treatmentSigrid Carlsson, Linda Drevin, Stacy Loeb, et al.
European Urology|April 19, 2017
Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation TherapyPrasanna Sooriakumaran, Tommy Nyberg, Olof Akre, et al.
Plos One|June 10, 2016
Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor GrowthSofia Halin Bergström, Maria Nilsson, Hanibal Adamo, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Prostate Cancer Radiation Therapy and Risk of Thromboembolic EventsCecilia Bosco, Hans Garmo, Jan Adolfsson, et al.
Clinical & Experimental Metastasis|April 28, 2017
Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in boneAnnika Nordstrand, Sofia Halin Bergström, Elin Thysell, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancerJózsef Horti, Anders Widmark, Arnulf Stenzl, et al.
The Prostate|December 5, 2019
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgensErik Bovinder Ylitalo, Elin Thysell, Camilla Thellenberg-Karlsson, et al.
The Prostate|February 2, 2017
High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone MetastasesErik Djusberg, Emma Jernberg, Elin Thysell, et al.
Pageof 10